Analysis of the Potent Prognostic Factors in Luminal-Type Breast Cancer / 한국유방암학회지
Journal of Breast Cancer
; : 401-406, 2012.
Article
在 En
| WPRIM
| ID: wpr-56439
Responsible library:
WPRO
ABSTRACT
PURPOSE: Luminal-type breast cancer has a good prognosis compared to other types, such as human epidermal growth factor receptor 2 and triple negative types. Luminal-type breast cancer is classified into luminal A and B, according to the proliferation index. We investigated the clinicopathological factors that affect the prognosis of the luminal-type subgroups. METHODS: We reviewed the medical records and the pathologic reports of 159 luminal-type breast cancer patients who were treated between February 2005 and November 2007. We divided luminal-type breast cancer into luminal A and B, according to Ki-67 (cutoff value, 14%) and analyzed the clinicopathologic factors, such as age at diagnosis, intensity score of estrogen receptor and progesterone receptor, histologic grade, and Bcl-2. Moreover, we compared the disease-free survival (DFS) of each group. RESULTS: In the univariate analysis, age (p=0.004), tumor size (p=0.010), lymph node metastasis (p=0.001), and Bcl-2 (p=0.002) were statistically significant factors in luminal-type breast cancer. In the multivariate analysis, lymph node (p=0.049) and Bcl-2 (p=0.034) were significant relevant factors in luminal-type breast cancer. In the subgroup analysis, the increased Bcl-2 (cutoff value, 33%) was related with a longer DFS in the luminal B group (p=0.004). CONCLUSION: In our study, luminal A breast cancer showed a longer DFS than luminal B breast cancer, further, Bcl-2 may be a potent prognostic factor in luminal-type breast cancer.
Key words
全文:
1
索引:
WPRIM
主要主题:
Phenobarbital
/
Prognosis
/
Breast
/
Breast Neoplasms
/
Receptors, Progesterone
/
Medical Records
/
Multivariate Analysis
/
Receptor, ErbB-2
/
Disease-Free Survival
/
Estrogens
研究类型:
Prognostic_studies
限制:
Humans
语言:
En
期刊:
Journal of Breast Cancer
年:
2012
类型:
Article